<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Feldmann</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Maini</surname>
    <given-names>R. N.</given-names>
   </name>
   <name>
    <surname>Woody</surname>
    <given-names>J. N.</given-names>
   </name>
   <name>
    <surname>Holgate</surname>
    <given-names>S. T.</given-names>
   </name>
   <name>
    <surname>Winter</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rowland</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed</article-title>. 
  <source>Lancet</source>
  <volume>395</volume> (
  <issue>10234</issue>), 
  <fpage>1407</fpage>â€“
  <lpage>1409</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30858-8</pub-id>
  <pub-id pub-id-type="pmid">32278362</pub-id>
 </mixed-citation>
</ref>
